MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE Trademark

Trademark Overview

On Wednesday, May 29, 2002, a trademark application was filed for MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE with the United States Patent and Trademark Office. The USPTO has given the MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE trademark a serial number of 76413439. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, January 6, 2014. This trademark is owned by Celgene Corporation. The MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research in the fields of chemicals and pharmaceuticals; scientific research services; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals
multiple pathways, multiple targets: drug discovery for celgene

General Information

Serial Number76413439
Word MarkMULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE
Filing DateWednesday, May 29, 2002
Status800 - REGISTERED AND RENEWED
Status DateMonday, January 6, 2014
Registration Number2911994
Registration DateTuesday, December 21, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 28, 2004

Trademark Statements

Disclaimer with Predetermined Text"DRUG DISCOVERY"
Goods and Servicesresearch in the fields of chemicals and pharmaceuticals; scientific research services; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 25, 2002
Primary Code042
First Use Anywhere DateSaturday, May 18, 2002
First Use In Commerce DateSaturday, May 18, 2002

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events

Event DateEvent Description
Thursday, December 21, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 6, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, January 6, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, January 6, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, December 23, 2013REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Monday, January 6, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 23, 2013TEAS SECTION 8 & 9 RECEIVED
Wednesday, February 10, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, February 5, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 4, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 29, 2009TEAS SECTION 8 & 15 RECEIVED
Thursday, June 16, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 21, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, September 28, 2004PUBLISHED FOR OPPOSITION
Wednesday, September 8, 2004NOTICE OF PUBLICATION
Tuesday, July 13, 2004PUBLISHED FOR OPPOSITION
Wednesday, June 23, 2004NOTICE OF PUBLICATION
Monday, April 19, 2004PAPER RECEIVED
Tuesday, April 13, 2004REG. CANCELLED - RESTORED TO PENDENCY
Friday, June 27, 2003SEC 7 REQUEST FILED
Friday, June 27, 2003PAPER RECEIVED
Tuesday, June 17, 2003REGISTERED-PRINCIPAL REGISTER
Tuesday, March 25, 2003PUBLISHED FOR OPPOSITION
Wednesday, March 5, 2003NOTICE OF PUBLICATION
Wednesday, February 5, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 5, 2003PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, September 29, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 24, 2002EXAMINER'S AMENDMENT MAILED
Wednesday, September 11, 2002ASSIGNED TO EXAMINER

Related Keywords

multiple celgene discovery targets pathways drug research chemicals pharmaceuticals fields services others products scientific testing development